A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis

被引:7
|
作者
Suarez, Miguel [1 ,2 ]
Martinez, Raquel [1 ]
Torres, Ana Maria [2 ]
Torres, Beatriz [3 ]
Mateo, Jorge [2 ]
机构
[1] Virgen Luz Hosp, Gastroenterol Dept, Ave Hermandad Donantes Sangre 1, Cuenca 16002, Spain
[2] Univ Castilla La Mancha, Inst Technol, Med Anal Expert Grp, Cuenca, Spain
[3] Obispo Polanco Hosp, Teruel, Spain
关键词
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Liver fibrosis; Machine learning; DISEASE; CLASSIFICATION; PREVALENCE;
D O I
10.1007/s10620-023-08031-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimNonalcoholic fatty liver disease (NAFLD) is a silent epidemy that has become the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is an advanced stage of NAFLD, which is linked to a high risk of cirrhosis and hepatocellular carcinoma. The aim of this study is to develop a predictive model to identify the main risk factors associated with the progression of hepatic fibrosis in patients with NASH.MethodsA database from a multicenter retrospective cross-sectional study was analyzed. A total of 215 patients with NASH biopsy-proven diagnosed were collected. NAFLD Activity Score and Kleiner scoring system were used to diagnose and staging these patients. Noninvasive tests (NITs) scores were added to identify which one were more reliable for follow-up and to avoid biopsy. For analysis, different Machine Learning methods were implemented, being the eXtreme Gradient Booster (XGB) system the proposed algorithm to develop the predictive model.ResultsThe most important variable in this predictive model was High-density lipoprotein (HDL) cholesterol, followed by systemic arterial hypertension and triglycerides (TG). NAFLD Fibrosis Score (NFS) was the most reliable NIT. As for the proposed method, XGB obtained higher results than the second method, K-Nearest Neighbors, in terms of accuracy (95.05 vs. 90.42) and Area Under the Curve (0.95 vs. 0.91).ConclusionsHDL cholesterol, systemic arterial hypertension, and TG were the most important risk factors for liver fibrosis progression in NASH patients. NFS is recommended for monitoring and decision making.
引用
收藏
页码:3801 / 3809
页数:9
相关论文
共 50 条
  • [31] Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis
    Sharma, Sachin
    Le Guillou, Dounia
    Chen, Jennifer Y.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023,
  • [32] Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis
    Hüseyin Saadettin Uslusoy
    Selim Giray Nak
    Macit Gülten
    World Journal of Hepatology, 2011, 3 (08) : 219 - 227
  • [33] Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis
    Sachin Sharma
    Dounia Le Guillou
    Jennifer Y. Chen
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 662 - 678
  • [34] GALLSTONE DISEASE IS NOT ASSOCIATED WITH LIVER FIBROSIS AND NONALCOHOLIC STEATOHEPATITIS IN NONALCOHOLIC FATTY LIVER DISEASE
    Yilmaz, Y.
    Ayyildiz, T.
    Akin, H.
    Colak, Y.
    Ozturk, O.
    Senates, E.
    Tuncer, I.
    Dolar, E.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S553 - S554
  • [35] Liver fibrosis in the context of nonalcoholic steatohepatitis: the role of adipokines
    Di Maira, Giovanni
    Pastore, Mirella
    Marra, Fabio
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2018, 64 (01) : 39 - 50
  • [36] Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis
    Uslusoy, Hiseyin Saadettin
    Nak, Selim Giray
    Gulten, Macit
    WORLD JOURNAL OF HEPATOLOGY, 2011, 3 (08) : 219 - 227
  • [37] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
    Angulo, P
    Keach, JC
    Batts, KP
    Lindor, KD
    HEPATOLOGY, 1999, 30 (06) : 1356 - 1362
  • [38] Disease Recurrence and Fibrosis Progression in Patients Transplanted for Nonalcoholic Steatohepatitis
    Bhati, Chandra
    Rivera, Maria
    Idowu, Michael O.
    Driscoll, Carloyn
    Kohli, Divyanshoo R.
    Stravitz, R. Todd
    Sanyal, Arun J.
    Gilles, HoChong
    Matherly, Scott C.
    Puri, Puneet
    Luketic, Velimir A.
    Lee, Hannah
    Sterling, Richard K.
    Siddiqui, Mohammad
    HEPATOLOGY, 2016, 64 : 508A - 508A
  • [39] Machine learning to predict progression of non-alcoholic fatty liver to non-alcoholic steatohepatitis or fibrosis
    Ghandian, Sina
    Thapa, Rahul
    Garikipati, Anurag
    Barnes, Gina
    Green-Saxena, Abigail
    Calvert, Jacob
    Mao, Qingqing
    Das, Ritankar
    JGH OPEN, 2022, 6 (03): : 196 - 204
  • [40] Correlation of clinical and laboratory factors with fibrosis in nonalcoholic steatohepatitis
    Lee, Tae Hoon
    Tekleyes, Fikadu
    Pacioles, Toni
    Shora, Waseem
    Ahmed, Monjur
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S161 - S162